Fairmount Funds Management LLC sold APGE
September 3, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC sold 51,166 shares of Apogee Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
51,166
Price
N/A
Total value
N/A
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateSeptember 3, 2026
Filing dateSeptember 3, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each reported security was disposed of, pursuant to the Agreement and Plan of Merger, dated as of June 18, 2026, among Andor LLC, Andor Merger Co., the Issuer and AbbVie Inc. (the "Merger Agreement"), in exchange for a cash payment equal to $135.11 per Share without interest (the "Merger Consideration").